SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-16-772405
Filing Date
2016-11-18
Accepted
2016-11-18 17:10:51
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-3 d293683ds3.htm S-3 176809
2 EX-4.4 d293683dex44.htm EX-4.4 325910
3 EX-5.1 d293683dex51.htm EX-5.1 32682
4 EX-23.1 d293683dex231.htm EX-23.1 2502
5 GRAPHIC g293683ex231footer.jpg GRAPHIC 15689
6 GRAPHIC g293683ex231logo.jpg GRAPHIC 9915
7 GRAPHIC g293683ex51logo.jpg GRAPHIC 9626
8 GRAPHIC g293683g14l32.jpg GRAPHIC 45879
  Complete submission text file 0001193125-16-772405.txt   651094
Mailing Address 10182 TELESIS COURT, 6TH FLOOR SAN DIEGO CA 92121
Business Address 10182 TELESIS COURT, 6TH FLOOR SAN DIEGO CA 92121 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-214721 | Film No.: 162008519
SIC: 2836 Biological Products, (No Diagnostic Substances)